Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity

Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity

Amphotericin B (AmB) is a potent antifungal successfully used intravenously to treat visceral leishmaniasis but depending on the <i>Leishmania</i> infecting species, it is not always recommended against cutaneous leishmaniasis (CL). To address the need for alternative topical treatments...

Full description

Bibliographic Details
Main Authors: Diana Berenguer, Maria Magdalena Alcover, Marcella Sessa, Lyda Halbaut, Carme Guillén, Antoni Boix-Montañés, Roser Fisa, Ana Cristina Calpena-Campmany, Cristina Riera, Lilian Sosa
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Pharmaceutics
Subjects:
amphotericin b
sepigel 305<sup>®</sup>
<i>leishmania infantum</i>
cutaneous leishmaniasis
topical treatment
Online Access:https://www.mdpi.com/1999-4923/12/2/149

Internet

https://www.mdpi.com/1999-4923/12/2/149

Similar Items